Loading ChartRhythms
Preparing market rhythm analysis...
Preparing market rhythm analysis...
Full Rhythm Report
COR • Stock • Health Care / Health Care Distributors
Cross-Horizon Read
COR's evidence points supportive across the available windows.
Generated 2026-10-05T11:20:00.000Z • Evidence c1ebab42
Price Data
A quote snapshot is available, but historical price data is not connected yet.
ChartRhythms displays a price chart only when real historical time-series data is available. No estimated or synthetic chart is shown.
0–3 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
• Additional dated, company-specific coverage in the 0–3 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
4–21 days
Supporting articles
0
Opposing articles
0
Neutral articles
0
Confidence basis
Supporting evidence
No supporting articles were found in this window.
Opposing evidence
No opposing articles were found in this window.
Catalysts
No specific catalysts were identified in this window.
Risks
No specific risk mentions were identified in this window.
Next proof points
22–90 days
The 22–90 days evidence set currently reads bullish.
Supporting articles
5
Opposing articles
0
Neutral articles
10
Confidence basis
Supporting evidence
• $100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
• 5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
• If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
Help improve this analysis
This feedback is saved locally for the MVP. Later, ChartRhythms can use this feedback to improve the strategy engine.
Important:
ChartRhythms provides source-based market summaries for research and informational purposes only. This is not financial advice and not a recommendation to buy, sell, or hold any security.
• Additional dated, company-specific coverage in the 4–21 days window.
Strengthens if
• Supporting evidence (0) grows relative to opposing evidence (0) in this window.
• No evidence is available for this window is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (0) in this window.
Sources in this window (0)
No sources are available for this window yet.
• Cencora Q3 Earnings Call Highlights
• Evercore ISI Group Maintains Outperform on Cencora, Raises Price Target to $350
Opposing evidence
No opposing articles were found in this window.
Catalysts
• RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330
• 5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
• Is Wall Street Bullish or Bearish on Cencora Stock?
• Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Diluted EPS Guidance Range Of $17.75-$17.95; Says Prime Vendor Agreement With Walgreens Remains Unchanged
• Cencora (COR) Q3 2026 Earnings Call Transcript
Risks
No specific risk mentions were identified in this window.
Next proof points
• Continued coverage in the 22–90 days window confirming the current read.
Strengthens if
• Supporting evidence (5) grows relative to opposing evidence (0) in this window.
• The most recent evidence in this window is not very fresh is resolved.
Weakens if
• Opposing evidence (0) grows relative to supporting evidence (5) in this window.
Showing 8 of 15 sources
RBC Capital Initiates Coverage of Cencora (COR) with Sector Perform Recommendation
Fintel • 2026-08-20 • Neutral
Open via Finnhub →RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330
Benzinga • 2026-08-19 • Neutral
Open via Finnhub →$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Benzinga • 2026-08-19 • Bullish
Open via Finnhub →5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call
Yahoo • 2026-08-14 • Bullish
Open via Finnhub →If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
Benzinga • 2026-08-13 • Bullish
Open via Finnhub →Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Diluted EPS Guidance Range Of $17.75-$17.95; Says Prime Vendor Agreement With Walgreens Remains Unchanged
Benzinga • 2026-08-12 • Neutral
Open via Finnhub →